Researchers using animals, even those in biocontainment, are now required to more than ever before to ensure that the animals do not suffer unduly, an expert to Kansas State University researchers during a Nov. 14 symposium.
James Swearengen with the Association for Assessment and Accreditation for Laboratory Animal Care International, spoke at the Emerging Infections Symposium, which commemorated the opening of the laboratory of Juergen Richt, the Regents Distinguished Professor of Diagnostic Medicine and Pathobiology at K-State. Richt is also a Kansas Bioscience Authority Eminent Scholar.
Symposium sponsors included the Bioscience Authority and the Heartland BioAgro Consortium, which is leading the effort to bring the National Agro and Bio-Defense Facility to Kansas. K-State is one of five finalists for that facility.
Swearengen told scientists that in the past accrediting agencies were less like to require researchers to use pain relievers if they thought the medications would alter the results. Now he said, a stronger case must be made against using analgesics. For example, he said, analgesics might alter the results of a study on inflammation and a case could be made for not using them in that instance.